» Articles » PMID: 10565949

Evaluation of Three Commercial Serological Tests with Different Methodologies to Assess Helicobacter Pylori Infection

Overview
Specialty Microbiology
Date 1999 Nov 24
PMID 10565949
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The sera of 142 Helicobacter pylori-positive and 32 H. pylori-negative patients were assessed by a desktop test (QuickVue), an enzyme-linked immunosorbent assay (ELISA) (HM-CAP), and a solid-phase, two-step chemiluminescent enzyme immunoassay (Immulite). These tests yielded sensitivities of 97, 97, and 91% and specificities of 97, 94, and 100%, respectively. In conclusion, the desktop test and the ELISA are more sensitive than the chemiluminescent enzyme immunoassay (P < 0.05). The chemiluminescent enzyme immunoassay has the advantage that it is fully automated.

Citing Articles

Diagnosis of infection: serology vs. urea breath test.

Imperial M, Tan K, Fjell C, Chang Y, Krajden M, Kelly M Microbiol Spectr. 2024; 12(11):e0108424.

PMID: 39329478 PMC: 11540150. DOI: 10.1128/spectrum.01084-24.


The association between Helicobacter pylori with nonalcoholic fatty liver disease assessed by controlled attenuation parameter and other metabolic factors.

Han Y, Lee J, Choi J, Kwak M, Yang J, Chung S PLoS One. 2021; 16(12):e0260994.

PMID: 34898613 PMC: 8668115. DOI: 10.1371/journal.pone.0260994.


Positive Association Between Helicobacter pylori Infection and Metabolic Syndrome in a Korean Population: A Multicenter Nationwide Study.

Lim S, Kim N, Kwon J, Kim S, Baik G, Lee J Dig Dis Sci. 2019; 64(8):2219-2230.

PMID: 30852768 DOI: 10.1007/s10620-019-05544-3.


Trends in the seroprevalence of Helicobacter pylori infection and its putative eradication rate over 18 years in Korea: A cross-sectional nationwide multicenter study.

Lim S, Kim N, Kwon J, Kim S, Baik G, Lee J PLoS One. 2018; 13(10):e0204762.

PMID: 30332428 PMC: 6192591. DOI: 10.1371/journal.pone.0204762.


Non-invasive diagnostic tests for Helicobacter pylori infection.

Best L, Takwoingi Y, Siddique S, Selladurai A, Gandhi A, Low B Cochrane Database Syst Rev. 2018; 3:CD012080.

PMID: 29543326 PMC: 6513531. DOI: 10.1002/14651858.CD012080.pub2.


References
1.
Werdmuller B, Vder Putten A, Veenendaal R, Lamers C, Loffeld R . Can screening for IgG antibodies against Helicobacter pylori be used in clinical practice? Omit endoscopy in seropositive or seronegative patients?. Dig Dis Sci. 1998; 43(10):2296-300. DOI: 10.1023/a:1026683026028. View

2.
Vaira D, Malfertheiner P, Megraud F, Axon A, Deltenre M, Hirschl A . Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. Lancet. 1999; 354(9172):30-3. DOI: 10.1016/s0140-6736(98)08103-3. View

3.
van der Hulst R, Rauws E, Koycu B, Keller J, Ten Kate F, Dankert J . Helicobacter pylori reinfection is virtually absent after successful eradication. J Infect Dis. 1997; 176(1):196-200. DOI: 10.1086/514023. View

4.
Meijer B, Thijs J, Kleibeuker J, van Zwet A, Berrelkamp R . Evaluation of eight enzyme immunoassays for detection of immunoglobulin G against Helicobacter pylori. J Clin Microbiol. 1997; 35(1):292-4. PMC: 229561. DOI: 10.1128/jcm.35.1.292-294.1997. View

5.
Parsonnet J, Hansen S, Rodriguez L, Gelb A, Warnke R, Jellum E . Helicobacter pylori infection and gastric lymphoma. N Engl J Med. 1994; 330(18):1267-71. DOI: 10.1056/NEJM199405053301803. View